Importance of Central Lab in Clinical Trials

With modern and advanced varieties of central laboratory proposals, a more thoughtful test selection process is needed. The importance of Central Lab and its approach creates a real partnership between the central laboratory and the test sponsor, adding value and helping to speed up the journey from molecule to the clinic.As...

Read More

Fujifilm evaluates Avigan to treat Covid-19 in US

Japanese company Fujifilm has launched a Phase II clinical trial of its influenza drug Avigan (favipiravir) to treat Covid-19 patients in the US. Approved in 2014 in Japan, Avigan specifically targets RNA polymerase required for influenza virus replication. This mechanism is also expected to have an antiviral effect on...

Read More

Glenmark gets approval to trial favipiravir for Covid-19 in India

Glenmark Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) to evaluate antivirial drug favipiravir in clinical trials to treat patients with Covid-19. Favipiravir is a generic version of Fujifilm Toyama Chemical’s influenza drug Avigan, which holds approval in Japan for treating new influenza virus infections. Glenmark developed the drug’s API and formulations internally. Following the regulatory approval, the new trial will assess the product in Covid-19 patients with mild to moderate infection. Around 150 patients will be enrolled for the study. Participants will be given favipiravir plus standard supportive care or only standard supportive care. Treatment duration of the trial is a maximum of 14 days and the total study duration will be a maximum of 28 days from randomisation. Glenmark Pharmaceuticals Global R&D executive...

Read More
Show Buttons
Hide Buttons